chrisvoncsefalvay/vaers-outcomes huggingface dataset:
sneezing; Itchy throat; Itchy face; breastfeeding; Itchy injection site; headache; Red circle on injection site; Rash on injection site; This spontaneous case was reported by a consumer and describes the occurrence of SNEEZING (sneezing), THROAT IRRITATION (Itchy throat), PRURITUS (Itchy face), EXPOSURE VIA BREAST MILK (breastfeeding) and VACCINATION SITE PRURITUS (Itchy injection site) in a 32-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 939676) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Allergy to antibiotic (allergy resolved as adult) and Seasonal allergy. Concomitant products included PARACETAMOL (TYLENOL) from 19-Jul-2021 to an unknown date and OXYMETAZOLINE HYDROCHLORIDE (CLARITIN ALLERGIC) from 19-Jul-2021 to an unknown date for Seasonal allergy.    On 18-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced SNEEZING (sneezing), THROAT IRRITATION (Itchy throat), PRURITUS (Itchy face), EXPOSURE VIA BREAST MILK (breastfeeding), VACCINATION SITE PRURITUS (Itchy injection site), HEADACHE (headache), VACCINATION SITE ERYTHEMA (Red circle on injection site) and VACCINATION SITE RASH (Rash on injection site). At the time of the report, SNEEZING (sneezing), THROAT IRRITATION (Itchy throat), PRURITUS (Itchy face), EXPOSURE VIA BREAST MILK (breastfeeding), VACCINATION SITE PRURITUS (Itchy injection site), HEADACHE (headache), VACCINATION SITE ERYTHEMA (Red circle on injection site) and VACCINATION SITE RASH (Rash on injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information was not provided.  patient is scheduled to receive 2th dose of Moderna vaccine on 18-Aug-2021.
1st Nausea than severe cold chills, fever and the whites of my eyes turned red. I also felt a burning sensation in the veins in my hands and feet.
RINGING IN THE EARS/ GETTING LOUDER AS TIME GOES BY - ITS BEEN ALMOST A YEAR SINCE MY FIRST SHOT, THE RINGING IS GETTING LOUDER I HAVE TO USE SOME FORM OF SOUND AT NIGHT TO SLEEP (LIKE RAIN FALLING FROM CALM) TO BE ABLE TO SLEEP WITH THE RINGING.
This spontaneous report as received from a healthcare worker refers to a 46 year old male patient. The patient's pertinent medical history included diabetes. The patient was allergy to penicillin. On 13-OCT-2014 the patient was vaccinated with a dose of PNEUMOVAX 23 (lot# K010522, expiration date 25-FEB-2016, dose and route were unknown). Concomitant therapies included metformin Extended Release Tablets. On 13-OCT-2014, the patient began to experience severe pain in the injection arm about 1 hour after the injection. The patient was seen in the emergency department of a hospital because his arm was so painful that he couldn't lift or move it. The patient was given a CT scan and X-ray to rule out stroke, was treated with ice and unspecified pain medication and then released from the hospital (unspecified date) without being admitted. The outcome of the events was unknown. The events were considered to be disability by the reporter. Additional information has been requested.
Information has been received from a consumer concerning her 19 year old daughter, who was vaccinated with the first dose of GARDASIL vaccine (date unspecified), and on 13-MAR-2007 was vaccinated with the second dose of GARDASIL vaccine. There was no concomitant medication. The consumer reported her daughter experienced "pain at the injection site" after the first vaccination. The patient's mother reported that on 21-MAR-2007, eight days after the second vaccination was administered, her daughter experienced a headache, neck pain, nausea and throat pain, and on approximately 22-MAR-2007, she felt "like her throat is closing up." On 22-MAR-2007 ("this morning"), her daughter felt worse when she woke up and was rushed to the emergency room. At the time of the report, the patient had not recovered. Additional information has been requested.  This is in follow-up to report (s) previously submitted on 4/13/2007. Follow up received from a physician included medical records received from the ER, and indicated that the patient was a college student, with no illness at the time of vaccination. The medical records confirmed concomitant vaccination with inlfuenza virus vaccine (unspecified) and meningococcal vaccine (unspecified), dates not specified (not confirmed by the physician). The ER medical records also indicated that on 22-MAR-2007, the patient presented with symptoms of headache (documented as at the base of the skull), and neck pain, with an original onset date of 21-MAR-2007 (also reported by the physician in follow up, an onset date of 22-MAR-2007). Other symptoms included "body aches," fever, chills, dizziness, weakness, and nausea (without vomiting). Vital signs in the ER included: blood pressure 110/70, pulse 100, respirations 20, and temperature 100.2F. The records documented that "airway/breathing" was within normal limits. Treatment included normal saline (intravenous), phenergan 12.5mg (intravenous), and TYLENOL. A complete blood count revealed the following: neutrophils 86.6%, lymphocytes 9.2%, and neutrophil count 9.3 (units not provided). The clinical impressionof the ER physician was noted as "acute febrile illness." The medical records documented that the patient "felt better" after treatment, and was discharged to home in "stable" condition on 22-MAR-2007. Vital signs at discharge were: BP 115/75, pulse 95, respirations 30, and temperature 99F, discharge instructions included acetaminophen or ibuprofen every 8 hours, and remain off of work/school for the next 2 days. At the time of this report, the physician confirmed that the patient had recovered from the events (date not specified). The follow up information (medical records) received on 09-APR-2007 also contained the following adverse expereinces: potassium low, 3.3 mmol/L (22-MAR-2007); sodium low, 132 mmol/L (22-MAR-2007); osmolality low, 272 mOsmol/kg (22-MAR-2007). No further informationis expected.
Awoke from nap this p.m. screaming for 2 hours was noted to have erythema and swelling of left leg. Erythema & swelling has subsided at office visit at 3:15pm, but infant still fussy.
This is a spontaneous report from a non-contactable consumer received via a Pfizer sales representative. An elderly female patient over the age of 65-years old of an unspecified ethnicity received PREVNAR 13 single dose on an unspecified date in 2014 reported as three weeks ago as a recommendation because of her age. The patient's medical history included that she received a "high dose" of flu vaccine and another vaccine and had a slight fever and arm was swollen after. The patient's concomitant medications were not reported. The patient experienced a slight fever and her arm was very swollen after she received the dose of PREVNAR 13. It was reported that the patient recovered from the fever and swelling on an unspecified date in 2014. No follow-up attempts possible. No further information expected.
palms, hands and feet were all itchy; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (palms, hands and feet were all itchy) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 06-Mar-2021, the patient experienced PRURITUS (palms, hands and feet were all itchy). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL A) for Symptomatic treatment, at an unspecified dose and frequency and PREDNISONE for Symptomatic treatment, at an unspecified dose and frequency. At the time of the report, PRURITUS (palms, hands and feet were all itchy) had not resolved.            Treatment medication also include: Steroid cream
1st and 2nd dose Pfizer COVID vaccine given as the booster instead of the Pfizer Bivalent booster
Pain in right arm, onset after injection persisting to time of report, sports medicine consult pending.
Patient received Moderna COVID vaccine on 4/7/21 and 5/5/21. On 12/31/21, patient tested positive for COVID. On 1/7/22, patient admitted to our inpatient facility with hypoxic respiratory failure, COVID-19 pneumonia, and AKI. As of today (1/13/22), patient is stil admitted in our med/surg unit.
Received second dose Pfizer Covid-19 vaccination on day 16.  First dose was given March 17, 2021 and would be due for second dose after April 7th.  April 2, 2021 falls out of the 4 day early grace period.
I had significant lower GI issues with sharp stomach pain for over two weeks. I went to see my dr. 8 days after the problem started. He prescribed Ciprofluxon to treat a possible bacterial infection. The pain and GI issues were resolved about a week after starting the medicine.
Pt developed shingles like rash across left cheek of face approximately 6 days after receiving vaccine.  Pt received 2 Rx's from Dr.  VALTREX and VICODIN.
This spontaneous report as received from a nurse refers to a 23 year old female patient. Concomitant therapies included DEPO-PROVERA. Approximately on an unknown date in 2009 the patient was vaccinated with VARIVAX (Merck). Later on 09-JUN-2014 when the patient was vaccinated with VARIVAX 1350 U (Merck) lot # K004419, expiration date 31-MAR-2016, dose 0.5 ml, route subcutaneous in left arm the patient developed injection site reaction on her left arm within 30 minutes of receiving VARIVAX (Merck). The reporter also stated that the patient was experiencing slight swelling, warmth, tenderness and a 4 inch by 4 and a half inch area of redness on her left arm at the injection site. The patient had reported to the nurse that she also had a few small blisters at the injection site and low grade fever. The lot number for diluents was reported as J003177, expiration date 12/2014. The patient was administered with Tuberculin skin test (09-JUN-2014): results unknown. The patient was treated with BENDARYL, Ibuprofen, TYLENOL for the events. The outcome of injection site reaction, low grade fever, redness on her left arm at the injection site and the patient is experiencing slight swelling, warmth, tenderness was reported as not recovered/not resolved. The outcome of few small blisters at the injection site was reported as recovered/resolved on an unknown date and the outcome of other event reported is unknown. The patient sought medical attention. No product quality complaint was involved. Additional information is not expected.
Redness, swelling and pain in (L) deltoid fever (lg) that started within 1 hr of receiving meningitis vaccine - see in-clinic 2 days later, symptoms persisting. Given BENADRYL 25 mg OTC.
chills, frequent urination, aching muscles and joints, sleepy, generally sick feeling, night sweat. Lasted approximately 24 hours.
I had issues with mental clarity after each vaccine. The symptoms seemed to resolve after 6 weeks-2-3 months, lessening with time. This last vaccine my mental clarity is worse and doesn?t seem to be resolving. My recall and short term memory has been affected quite severely.
Had "fainting" type rxn where body got very "rigid"; taken to ER; ER record: hx of eyes rolling, falling backwards, unresponsive w/frothing, briefly tonic followed by post-ictal period; mucoid rhinorrhea; viral syndrome; febrile sz; t100.3R
Site: Pain at Injection Site-Severe, Systemic: Allergic: Rash (specify: facial area, extremeties)-Mild, Systemic: Lymph Node Swelling-Severe, Error: Shoulder Joint Injury (prolonged pain, tingling, etc.)-, Additional Details: pain radiating up to the neck region as well as painful lump near breast of injection site
Allergic reaction; hot to touch over area; Edema; Swollen arm; Painful arm; increased cough; Rhinitis; Itching at injection site; Redness below the injection site; myalgia; arthralgia; Fever; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Swollen arm), PAIN IN EXTREMITY (Painful arm), FEELING HOT (hot to touch over area), OEDEMA (Edema) and HYPERSENSITIVITY (Allergic reaction) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030M20A and 028L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Drug allergy (Allergic to omnicef), Drug allergy (Allergic to chlorhexidine), Asthma and Adhesive tape allergy. Concomitant products included ROSUVASTATIN CALCIUM (CRESTOR) for High cholesterol, FEXOFENADINE HYDROCHLORIDE (ALLEGRA) for Seasonal allergy, CALCIUM CARBONATE, COLECALCIFEROL (VITAMIN D 2000) for Vitamin D deficiency, SPIRONOLACTONE, MONTELUKAST SODIUM (SINGULAIR) and UBIDECARENONE (CO Q-10) for an unknown indication.   On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 24-Feb-2021, the patient experienced PERIPHERAL SWELLING (Swollen arm), PAIN IN EXTREMITY (Painful arm), OEDEMA (Edema), COUGH (increased cough), RHINITIS (Rhinitis), VACCINATION SITE PRURITUS (Itching at injection site), VACCINATION SITE ERYTHEMA (Redness below the injection site), ARTHRALGIA (arthralgia) and PYREXIA (Fever). 24-Feb-2021, the patient experienced MYALGIA (myalgia). On an unknown date, the patient experienced FEELING HOT (hot to touch over area) and HYPERSENSITIVITY (Allergic reaction). The patient was treated with PARACETAMOL (TYLENOL) on 24-Feb-2021 at an unspecified dose and frequency and PREDNISONE at a dose of 20 milligram. On 08-Mar-2021, PAIN IN EXTREMITY (Painful arm), OEDEMA (Edema), COUGH (increased cough), RHINITIS (Rhinitis), VACCINATION SITE PRURITUS (Itching at injection site) and VACCINATION SITE ERYTHEMA (Redness below the injection site) had resolved. At the time of the report, PERIPHERAL SWELLING (Swollen arm), FEELING HOT (hot to touch over area) and HYPERSENSITIVITY (Allergic reaction) outcome was unknown and MYALGIA (myalgia), ARTHRALGIA (arthralgia) and PYREXIA (Fever) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   For asthma patient is using breo inhaler and albuterol inhaler.    This case was linked to MOD-2021-027960 (Patient Link).
Initial report received from a health care professional in the USA on Aug 31 2005. A 16 year old male patient developed bilateral itchy hives in the groin area, behind the ears and in the right axillary 24 hours after receiving the injection of Menactra, lot number U1767AA in the left deltoid on Aug 19 2005. No treatment was reported and symptoms resolved. No further information expected.
1.  VERY TENDER DELTOID AND UPPER LEFT ARM. 2.  GENERALIZED ACHING OF ENTIRE BODY. 3.  UNABLE TO SLEEP FOR 6 HOURS. 4.  TOOK 500 MG TYLENOL. 5.  ACHING AND LOW-GRADE TEMPERATURE CEASED. 6.  FELL ASLEEP FOR 8 HOURS. 7.  AWOKE AND PAIN HAD SUBSIDED. 8.  DID NOT INGEST FOOD BUT DID DRINK WATER. 9.  ON 03/11/2021 AWOKE AND EXPERIENCED NO FURTHER PROBLEMS.
I woke up at 0500 the day following vaccine administration with moderate to severe intestinal cramping.  I have never had this feeling. This persisted at that level for the day. It continued albeit milder, for the next 36 hours. It is now Monday morning and I still have stomach pain. It is not accompanied by any nausea or diarrhea.  I do feel some mild constipation and bloating. None of this is typical for me. I have had no changes in eating that I can correlate. No one else in my family has been ill.
Itchy patch on arm at injection site 8 days after injection. No fever, swelling, or pain and I feel completely fine otherwise.
Vaginal bleeding like a period lasting 5 days then no bleeding for 7 days then vaginal bleeding for 17 days so far.
Trouble getting off of the couch; Back ache in the small of his back; Chills; Slight fever; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills), PYREXIA (Slight fever), DYSSTASIA (Trouble getting off of the couch) and BACK PAIN (Back ache in the small of his back) in a 78-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026b21a) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included LOSARTAN for an unknown indication.   On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 05-Apr-2021, the patient experienced CHILLS (Chills), PYREXIA (Slight fever), DYSSTASIA (Trouble getting off of the couch) and BACK PAIN (Back ache in the small of his back). On 09-Apr-2021, CHILLS (Chills), PYREXIA (Slight fever) and DYSSTASIA (Trouble getting off of the couch) had resolved. At the time of the report, BACK PAIN (Back ache in the small of his back) had resolved. Not Provided          Treatment information was not provided.   Action taken with mRNA-1273 in response to the events was  not applicable.  For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   This case was linked to US-MODERNATX, INC.-MOD-2021-080004 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-080004:1 st dose case
02/23/22  presents as transfer "from her LTAC due to hypotension during hemodilaysis". PMHx of "ESRD (Started dialysis on 11/10/21), obesity, CHF, chronic afib (on eliquis), TIIDM, and HTN"
temp 105 1 day following inj;pt was irritable, feeding poor;r/o sepsis w/up;CSF, blood cult negative;CBC negative;
13 hours after the injection, I experienced chills, nausea, then sweats, headache, muscle ache.  Next day, tired and got chills for a couple hours in the evening.  Following day, felt okay.
At approximately 3;15 PM, I was administered the 2nd dose of Moderna Covid-19 Vaccine(EUA. At approximately 5:30 pm, my blood sugars rose in excess of 400 mg/dl, felt lightheaded followed by quick onset of high pressure and volume diarrhea. I was in my girlfriend's home and was barely able to get to the toilet in time. The diarrhea appeared pea soup green in color and consistency and very smelly.  Of interest, my girlfriend who also received the second dose of the Moderna vaccine on the same date, time and location, was awaken at approximately 2:00 AM with the same rapid onset of diarrhea.  On the second day following the vaccine, we both had elevated temperatures of 101.5 and 102 lasting approximately 24 hours.
rash in left breast, left back; diarrhea; chills; sore left arm; This spontaneous case was reported by a physician and describes the occurrence of DIARRHOEA (diarrhea), CHILLS (chills), VACCINATION SITE PAIN (sore left arm) and RASH (rash in left breast, left back) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025520-28) for COVID-19 vaccination.     Previously administered products included for an unreported indication: SHINGRIX. Concomitant products included ENTECAVIR for Hepatitis B, ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) and METFORMIN for an unknown indication.    On 23-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Jan-2021, the patient experienced DIARRHOEA (diarrhea), CHILLS (chills) and VACCINATION SITE PAIN (sore left arm). On 27-Jan-2021, the patient experienced RASH (rash in left breast, left back). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL A) at a dose of unknown. At the time of the report, DIARRHOEA (diarrhea), CHILLS (chills), VACCINATION SITE PAIN (sore left arm) and RASH (rash in left breast, left back) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   patient also had corpress 0.5mg 2 in the evening and some unknown medicine for liver transplant as concomitant medications.; Reporter's Comments: \; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. Further information has been requested for the event "rash that looks like shingles"
Headache, Myalgia, Fever, ErythemaMultiform, Pain in feet Narrative:
Patient states she developed a 4" x 2" red localized reaction by the injection site. Non painful, not itching; just red and warm to touch. No other symptoms. I had patient come in and show me reaction and advised patient to keep in touch Kw/PCP. I will also call and monitor patient over next few days.
The patient developed chest discomfort, and was diagnosed with myocarditis.  Myocarditis was confirmed by cardiac MRI.  Symptoms started shortly after the 2nd dose of the COVID19 Pfizer vaccine.
Has soreness today with triceps injection; It was given subcutaneously in his triceps, when it should be given intramuscularly in the deltoid; He received 2nd dose of Covid vaccine today and received it subcutaneously on his triceps which he thinks is an incorrect site of administration; This is a spontaneous report from a contactable physician (patient). A male patient of unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), subcutaneously in the triceps on 07Jan2021 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The physician called about the COVID-19 vaccine and stated that he was given his second dose that morning after the three weeks, and he was pretty sure it was given subcutaneously in his triceps, when it should be given intramuscularly in the deltoid. He says that he would like to inquire about recommendations for his next step, since it was given not per recommendations, and see if there is anything in Pfizer's recommendations such as check for antibodies in a couple weeks or to get another injection. He says that this injection was done a lot lower than his first dose, and he was reading Pfizer vaccine recommendations to be the deltoid, and he is guessing they gave it to him in the triceps subcutaneously. He says after the first shot, he had mild arm soreness with no other symptoms, he so far has soreness that day with triceps injection. He would like to know what recommendations are to do next, or if there is a higher risk of side effects since it was given into soft tissue, if there is any information or studies with data about subcutaneous administration of this vaccine. The outcome of the events was unknown.   Information on the lot/batch number has been requested.
I don't know the exact DTAP, you would have to get with the doctor for all of that information.   I had my yearly physical in August and everything was fine.  I got the DTap that day and within a month or 2 I had lumps in my breast and lumps in my vagina.  The only thing that changed was the vaccine.